The United Arab Emirate -based Gulf Pharmaceutical Industries a.k.a. Julphar announced that it would build the continent's largest injectable medicine producing facility in Ethiopia with an investment outlay of USD 50 million. Hassan Jibreel , senior director of corporate development for the company, told The Reporter last Wednesday that Julphar has found Ethiopia to be the hub of Africa and a center for many other international organizations.
↧